Skip to Main Content

Hello, everyone, and welcome to the middle of the week. Yes, we know, it can be hard to tell sometimes which day is which, but here we are. So consider it an accomplishment, given the challenges and stress confronting us all, and treat yourself to a hot cup of stimulation. A little focus is a good thing, after all. We are rifling through our stash of hazelnut, in fact. Meanwhile, here is a fresh pile of tidbits to help you along. We hope today is productive and manageable. And remember, keep on the sunny side, and keep safe…

A U.S. government-run study of remdesivir, the experimental Gilead Sciences (GILD) drug being tested to treat Covid-19, showed the medicine is effective against the novel coronavirus, STAT notes. Gilead issued a statement saying, “We understand that the trial has met its primary endpoint.” The finding — although difficult to fully characterize without any data for the study — would represent the first treatment shown to improve outcomes in patients infected with the virus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!